[Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units]

F Álvarez Lerma1, P Olaechea Astigarraga2, M Palomar Martínez3

  • 1Servicio de Medicina Intensiva, Hospital del Mar, Parc de Salut Mar, Barcelona, España.

Medicina Intensiva
|April 10, 2014
PubMed
Abstract

Insights

Respiratory fungal infections caused by Aspergillus spp. in Spanish intensive care units (ICUs) are infrequent but linked to high mortality. Risk factors include prior hospital ward admission, immunosuppression, and severe sepsis.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Mycology

Background:

  • Respiratory fungal infections, particularly those caused by Aspergillus spp., pose significant morbidity and mortality risks in critically ill patients.
  • Early identification and management are crucial for improving outcomes in intensive care unit (ICU) settings.

Purpose of the Study:

  • To determine the incidence of Aspergillus spp. respiratory infections in Spanish ICUs, irrespective of infection origin.
  • To characterize the clinical presentation, outcomes, and prognostic factors associated with these infections.

Main Methods:

  • An observational, retrospective, multicenter study analyzed data from 108,244 patients in the ENVIN-HELICS registry (2006-2012).
  • Included patients had confirmed Aspergillus spp. respiratory infections in Spanish ICUs.
  • Logistic regression identified independent predictors of in-hospital mortality.

Main Results:

  • The study identified 267 cases of Aspergillus spp. respiratory infections (2.46 per 1000 ICU patients).
  • Common presentations included ventilator-associated pneumonia (34.8%) and pneumonia unrelated to ventilation (44.9%).
  • High ICU (57.3%) and hospital (59.6%) mortality rates were observed, with independent risk factors being prior hospital ward admission, immunosuppression, and severe sepsis/septic shock.

Conclusions:

  • Aspergillus spp. respiratory infections are uncommon in Spanish ICUs but affect a vulnerable patient subset.
  • These infections are associated with substantial mortality, influenced by non-modifiable risk factors.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.4K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768